NCT02061657View on ClinicalTrials.gov

Impact of Misoprostol on Blood Loss In Myomectomy Operations

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Leiomyoma
Interventions
DRUG

Misoprostol

25 patients undergoing myomectomy operation will receive two tablets of misoprostol (400 mcg) rectally two hours before the operation

DRUG

Placebo( for misoprostol)

Include 25 patients undergoing myomectomy operation will not receive misoprostol before the operation.

Trial Locations (1)

Unknown

Ain Shams University, Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02061657 - Impact of Misoprostol on Blood Loss In Myomectomy Operations | Biotech Hunter | Biotech Hunter